Chicago, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Vaccine Adjuvants Market is projected to grow from USD 1.5 billion in 2022 to USD 1.6 billion by 2027, at a CAGR of 1.7% from 2022 to 2027, according to a new report by MarketsandMarkets™. The growth of the market is projected to be driven by collaborations and partnerships among market players for the development of vaccine adjuvants, an increasing number of COVID-19 vaccines in the development pipeline and increasing focus on immunization programs.
Continue reading your article with a FrontPage News Subscription
Already a Subscriber? Sign In
VIEW SUBSCRIPTION OPTIONS
Support independent journalism by subscribing